← Back to Search

Educational Support for Lung Cancer Screening

N/A
Recruiting
Research Sponsored by Ronald Myers
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial looks at how educating patients and providers on lung cancer screening can help find the cancer earlier and increase screening rates.

Who is the study for?
This trial is for adults aged 50-77 who currently smoke or quit within the last 15 years, with a significant smoking history. They must be able to communicate in English or Spanish and have an upcoming primary care visit. Excluded are those recently hospitalized, with dementia, prior lung cancer, or recent CT scans.
What is being tested?
The study evaluates if education and counseling can increase lung cancer screening rates among smokers or recent quitters. It involves survey administration, electronic health record review, and educational activities aimed at both healthcare providers and patients.
What are the potential side effects?
Since this trial focuses on education and counseling rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience stress or anxiety related to learning about their risk of lung cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of initial lung cancer screening (LCS)
Secondary study objectives
Diagnostic follow up after initial lung cancer screening
Referral for LCS
Repeat annual lung cancer screenings within 11-16 months of original screening
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Group A (Providers): (survey, online educational activity)Experimental Treatment2 Interventions
Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
Group II: Group A (Patients): (EHR, educational activity, counseling))Experimental Treatment3 Interventions
Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
Group III: Group B (Patients): (survey)Active Control2 Interventions
Patients undergo EHR review on study and complete telephone survey throughout the trial.
Group IV: Group B (Providers): (survey)Active Control1 Intervention
Participants complete survey at baseline and end of study survey.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,178 Total Patients Enrolled
Ronald MyersLead Sponsor
Thomas Jefferson UniversityLead Sponsor
456 Previous Clinical Trials
148,574 Total Patients Enrolled

Media Library

Group A (Patients): (EHR, educational activity, counseling)) Clinical Trial Eligibility Overview. Trial Name: NCT05679349 — N/A
Lung Cancer Research Study Groups: Group B (Patients): (survey), Group A (Patients): (EHR, educational activity, counseling)), Group A (Providers): (survey, online educational activity), Group B (Providers): (survey)
Lung Cancer Clinical Trial 2023: Group A (Patients): (EHR, educational activity, counseling)) Highlights & Side Effects. Trial Name: NCT05679349 — N/A
Group A (Patients): (EHR, educational activity, counseling)) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05679349 — N/A
~548 spots leftby Apr 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top